Catalyst Funds Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-800
Closed -$35.2K 1372
2024
Q1
$35.2K Buy
+800
New +$35.4K 0.01% 638

Other funds holding IRMD

Catalyst Funds Management's IRMD Position: Q2 2024 in Review

Catalyst Funds Management sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 800 shares — an estimated $35.2K sold.

Catalyst Funds Management first reported a position in IRMD in Q1 2024 and held it in 1 quarter. The position peaked at $35.2K in Q1 2024. 138 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.

  • Catalyst Funds Management reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 800 iRadimed shares in Q2 2024, an estimated $35.2K.
  • Catalyst Funds Management first reported a position in iRadimed in Q1 2024 and held it in 1 quarter.
  • Catalyst Funds Management's iRadimed position peaked at $35.2K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.

Based on Catalyst Funds Management's 13F filing for Q2 2024, filed 18 Dec 2024.